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Serious complications can occur during the study of 
patients who develop allergic reactions while under treatment 
with multiple drugs. In such cases, it is necessary to conduct 
an exhaustive investigation of the drugs involved and 
comprehensive allergy tests with assessment of immediate 
and late reactions.
We present the cases of 2 patients that developed a late 
reaction to nystatin.
Case 1
 
A 63-year-old man with lung carcinoma and no history 
of contact dermatitis presented an intense erythematopapular 
eruption on his arms, back, and groin after a 3-day course of 
corticosteroids following chemotherapy. He had tolerated an 
initial chemotherapy cycle with paclitaxel and cisplatin well. The 
patient had received the following drugs: cisplatin, paclitaxel, 
granisetron, bemiparin, osmofundin, metoclopramide and 
was still under treatment with levothyroxine and nystatin 
(Mycostatin oral suspension). Nystatin was stopped and the 
lesions resolved within 7 days.
Patch tests performed with the European standard series 
of allergens and cisplatin, paclitaxel, granisetron, bemiparin, 
osmofundin, metoclopramide and Mycostatin oral suspension 
were positive only to balsam of Peru (+) at 48 and 96 hours. 
Interestingly, the patient tolerated the subsequent chemotherapy 
cycles with the same drugs except nystatin well.
Case 2
 
A 45-year-old woman, admitted to the psychiatry 
department of our hospital, presented pruriginous erythema 
on the face and neck that had appeared 3 days earlier. She 
had a history of contact dermatitis to metals. The patient was 
under treatment with amoxicillin and ibuprofen for a dental 
treatment and nystatin (Mycostatin oral suspension) for an oral 
fungal infection related to the use of antibiotics. Amoxicillin 
and ibuprofen were discontinued but the skin eruption persisted 
for 1 month at other sites. 
Six months later, the patient developed an erythematous 
reaction without hives on the face and neck several hours 
after being started on a course of nystatin (Mycostatin oral 
suspension) administered by error. 
Patch tests performed with the European standard series 
of allergens, ibuprofen, amoxicillin and Mycostatin oral 
suspension, and the patient’s perfume and bath gel were 
positive only for the fragrance mix (+++) at 96 hours. 
Nystatin was replaced by fl uconazole and the lesions 
showed progressive improvement over 7 to 10 days, with all 
symptoms disappearing within 1 month.
There was no apparent relationship between patch test 
positivity and the drugs administered in the 2 patients. 
On reviewing the composition of the drugs, we found 
that the commercial preparation of nystatin [1] (sodium 
saccharine, saccharose, ethanol, carboxymethyl cellulose, 
cinnamic aldehyde, peppermint essence, cherry flavor, 
disodium hydrogen phosphate, glycerin, methylparaben, and 
propylparaben) contained cinnamic aldehyde, which is also 
found in balsam of Peru and fragrance mix I.
We do not know why one of the patients had a positive 
reaction to balsam of Peru or why the other had a positive 
reaction to the fragrance mix, and we were unable to perform 
a specifi c patch test to confi rm cinnamic aldehyde sensitization 
because the patients do not live in our city.
False negative results are common in patch testing with 
drugs [2]. In our patients, we believe that the concentration of 
cinnamic aldehyde in the nystatin preparation might be lower than 
that needed to yield a positive test reaction [3]. The concentration 
of cinnamic aldehyde in Mycostatin, however, is unknown. 
There are several reports of systemic contact dermatitis after the 
ingestion of cinnamic aldehyde [4], an ingredient used in products 
such as soft drinks, toothpaste, cinnamon oil, chewing gum, and 
chocolate. The patients involved had positive patch test reactions 
to balsam of Peru, fragrance mix, or cinnamic aldehyde. In our 
patients, we were unable to obtain direct evidence of cinnamic 
aldehyde sensitization because this compound was not evaluated 
in the patch tests performed.
In conclusion, we wish to highlight the importance of 
carefully evaluating allergy test results even in the absence of 
a clear cause-effect relationship.
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Figure. Reaction to patch test with phenylephrine on residual lesion at 
96 hours.
Fixed drug eruption (FDE) is a well-known entity that can 
be caused by a variety of drugs. In many cases, a single drug 
is responsible for FDE but in some patients, FDE lesions can 
develop following the administration of multiple drugs with 
common chemical structures. This is different from a phenomenon 
known as polysensitivity, where drugs or other agents with totally 
different chemical structures can cause exacerbations similar to 
those caused by the inducing drug [1,2].
A 22-year-old woman was referred for evaluation 
of an allergic reaction to Couldina (acetylsalicylic acid, 
chlorpheniramine, phenylephrine and ascorbic acid) on 3 
occasions a month apart. Each reaction consisted of an identical 
eruption at the same place on the left forearm. These eruptions, 
which consisted of an itchy dusky-red macule, appeared within 
12 to 24 hours of taking an initial dose of Couldina, a drug 
used to treat colds without fever. The drug was discontinued 
and the lesion improved within 5 days, leaving a residual 
hyperpigmented lesion for some weeks. Two months later, an 
identical lesion appeared in the same place when the patient 
took paracetamol for a headache.
She subsequently tolerated Rino-ebastel (ebastine and 
pseudoephedrine), a combination drug that the patient 
occasionally uses to treat rhinitis, on several occasions.
Patch tests were performed with acetylsalicylic acid (10% 
in petrolatum), paracetamol (20% in petrolatum) phenylephrine 
(1% in aqueous solution), adrenaline (undiluted), and 
ephedrine and pseudoephedrine (1% in aqueous solution and 
petrolatum). The patches were applied to the patient’s back 
and a residual lesion using Curatest (Lohmann, Marti Tor, 
Barcelona, Spain) and removed after 48 hours. Readings 
were carried out at 48 and 96 hours, as recommended by the 
International Contact Dermatitis Research Group [3]. All the 
results were negative except for phenylephrine on the residual 
lesion at 96 hours (Figure).
In an oral challenge test, the patient showed good tolerance 
to acetylsalicylic acid but developed a positive reaction to 
paracetamol. The reaction consisted of the appearance of an 
identical erythematous violaceous macule in exactly the same 
place as the other lesions 8 hours after a dose of 500 mg of 
paracetamol. 
Phenylephrine hydrochloride is a sympathomimetic 
drug used in ophthalmology and otorhinolaryngology for 
its mydriatic and vasoconstrictive properties. It is found in 
many drug products and is typically administered orally and 
locally, although it has been used parenterally in the treatment 
of hypotensive states.
We expected to fi nd cross-reactivity between phenylephrine 
and other sympathomimetic drugs belonging to the phenylamine 
family but this is a controversial issue [4,5]. Ephedrine and 
pseudoephedrine are derived from a phenylpropanolamine 
skeleton, while phenylephrine and epinephrine are modifi ed 
forms of phenylethanolamine and differ in terms of 
substitutions in the aromatic part of the molecule. These 
differences in chemical structures might explain the absence 
of cross-reactivity, although another explanation, proposed by 
Barranco et al [5], could be the insuffi cient standardization of 
diagnostic methods.
The drug concentrations and vehicles used to perform the 
patch tests on our patient were recommended by the pharmacy 
department at our hospital on the basis of concentrations found 
in commercial preparations.
The literature contains many reports of contact dermatitis 
to phenylephrine [6,7] and other sympathomimetic agents [8,9] 
but to the best of our knowledge, this is the fi rst report of an 
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FDE to phenylephrine. Paracetamol-induced FDEs, in contrast, 
are more common [10,11].
Our clinical and patch test fi ndings suggest that our patient 
might have been specifi cally sensitized to phenylephrine. 
Moreover, this is a case of FDE induced by 2 unrelated 
chemical substances, paracetamol and phenylephrine.
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Studies conducted in Europe have demonstrated that house 
dust in mountainous areas contains very few or no domestic 
mites [1]. In Ecuador, in contrast, recent studies of domestic 
mite fauna in high-altitude cities (2500-2800 m) revealed the 
frequent and abundant presence of mites and their allergens 
in house dust samples [2]. These discrepancies between high-
altitude areas in Europe and the Andean regions of South 
America might be due to climatic differences and particularly 
differences in ambient humidity. 
Little is known, however, about the presence of domestic 
mites in altitudes above 3000 m in Andean regions. The 
shortage of dwellings and practical sampling diffi culties make 
the collection of samples in this environment quite diffi cult.
We present the results of an analysis of dust samples 
collected in May 2006 at the Cotopaxi volcano mountain refuge 
José Ribas. The volcano lies 75 km south of the equator in 
Ecuador (78º26’W 00º39’S 5897 m) and is considered by many 
to be the highest active volcano in the world. It experiences 
sudden changes in weather and a daily variation in temperature 
from –5ºC to –20ºC. The mean relative humidity is ±75% but 
humidity levels fl uctuate from less than 20% to saturation.
The mountain refuge is located at an altitude of 4800 m; 
the 2-fl oor structure holds over 100 climbers, who usually stay 
overnight before starting their ascent. The fi rst fl oor contains 
a social area and a basic kitchen and the second fl oor is used 
exclusively for sleeping purposes. There is no wall or fl oor 
humidity, and no carpets, vegetables, or other stored materials. 
The restroom area is located outside the main house.
Because there was no electric power to run a vacuum 
cleaner, dust samples were collected by sweeping the fl oor 
of the bunk bed area. Ten samples were collected, each 
from an area measuring 1 m2. All the samples were frozen 
for at least 48 hours to prevent the possible proliferation of 
mites. Dust samples were weighed and logged and 20-mg 
aliquots were suspended in a saturated saline solution and 
analyzed under a stereoscope. All the mites in each sample 
were collected using a fi ne needle and placed in 2 drops of 
Hoyer’s medium on a microscope slide. Afterwards, the slide 
was covered and allowed to dry at 50ºC for 24 hours. The 
slides were inspected under a microscope and the mite species 
identified in accordance with international identification 
keys and then counted. The frequency and abundance of 
mite species is shown in the Table. Both adult and immature 
forms of Glycphagus domesticus were found, suggesting that 
this species is able to complete its life cycle in this habitat. 
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Table. Frequency and Abundance of Mite Species in 10 Samples Collected 
at the Cotopaxi Volcano Refuge (Altitude, 4800 m)
  
  No. of Geometric Range
  Positive Mean (mites/g)
  Samples (mites/g)  
Total mites 8 12.7 57.4-4.6
Glycyphagus
domesticus 5 11.1 38.2-4.6
Dermatophatgoides
pteronyssinus 3 5.6 6.4-4.6
Tydeidae species 2 5.4 6.4-4.6
Glycyphagus fusca 1 6.4
Tarsonemus species 1 47.8
Only adults of Dermatophagoides pteronyssinus were found, 
however, indicating the possibility of passive transport via 
human clothing, as has been suggested for mite allergens found 
in high-altitude refuges in Switzerland [3]. 
No detectable levels of Der p1 or Der f1 allergens were 
observed in the samples using enzyme-linked immunosorbent 
assay (Indoor Biotechnologies, Charlottesvilles, Virginia, 
USA) but we must emphasize the presence of allergenic mites, 
albeit at low levels, in a relatively high number of samples, 
despite the fact that the fl oor is not the favorite habitat for 
these species. Their presence in this extreme habitat highlights 
their ability to adapt to human environments and should be 
taken into account in environmental control programs. The 5 
species found are constituents of domestic mite fauna described 
as present in mattress dust collected in cities of Ecuador. 
Additionally, G domesticus has been described as a cosensitizer 
for 11% of asthmatic and rhinitic residents of Quito (2800 m), 
and as an exclusive sensitizer in 0.5% of these [2]. 
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It is common practice to add fl avor-enhancing molds to 
traditional foods such as dry sausage, salami, Spanish ham, and 
French cheese in Central and Southern Europe [1]. In Northern 
Europe, where the addition of molds to meat products is not 
permitted, there are studies that have demonstrated considerable 
levels of contamination by Penicillium, Cladosporium, and 
Eurotium molds in equipment and raw materials used during 
the manufacture of meat products [2]. Occupational respiratory 
diseases due to prolonged or repeated exposure to organic dust 
containing molds (rhinoconjunctivitis, asthma, hypersensitivity 
pneumonitis, and organic dust toxic syndrome) among food 
industry workers is also well documented [3]. Nevertheless, 
food allergy to mold proteins is rare [4], with very few reports 
in the literature [5]. 
We report the case of a 24-year-old man diagnosed with 
rhinoconjunctivitis and asthma due to allergy to pollens, 
mites, and molds at the age of 9 years. In the past year he had 
experienced 2 episodes of facial angioedema immediately upon 
ingestion of a few slices of dry sausage, which he had tolerated 
previously on many occasions. The symptoms subsided 
spontaneously in under 6 hours. He had avoided the sausage 
since and tolerated all other types of meat products.
We performed skin prick tests to common aeroallergens, 
meats (pork, beef, veal, chicken, and rabbit) and other common 
foodstuffs (egg, cow’s milk, pepper, garlic, peanut, and nut), 
as well as prick-by-prick tests with the outer skin and the meat 
of the suspect sausage. Total serum immunoglobulin (Ig) E 
and specifi c IgE determinations were performed using the 
CAP system (Phadia, Uppsala, Sweden). A microbiological 
analysis and culture of the sausage skin was carried out in 
order to identify possible contaminants.
After obtaining the results of the aforementioned tests, 
we performed a labial food challenge in which the outer skin 
of the sausage was placed in brief contact with the patient’s 
external lower lip.
Skin prick tests were positive for grass pollen, house 
dust mites, and molds (Alternaria alternata, Penicillium 
notatum, Mucor racemosus, and Pullularia, Stemphylium, 
Helminthosporum, and Fusarium spp.), and negative for all 
the food allergens tested. The prick-by-prick was positive for 
the outer sausage skin (7x7-mm wheal) and negative for the 
sausage meat.
Total serum IgE was 1513 kU/L. Specifi c IgE determinations 
were positive for Alternaria alternata (58 kU/L), Mucor 
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Figure. Colonies of Penicillium spp. isolated in the sausage skin.
racemosus (2.67 kU/L), and Penicillium notatum (3.03 kU/L). 
The microbiologists isolated Penicillium and Mucor spp. in the 
sausage skin. The colonies can be seen in the Figure.
The labial challenge test yielded a positive result, with 
onset of angioedema of the lips, tongue, and uvula within 
5 minutes. The symptoms were treated with intravenous 
methylprednisolone and dexchlorpheniramine and subsided 
in 2 hours.
The diagnosis was facial angioedema after dry sausage 
ingestion due to IgE-mediated allergy to Penicillium and 
Mucor spp. The patient was advised to avoid all products 
commonly contaminated with molds such as dry fermented 
sausages, Spanish ham, foie gras, and French cheeses such as 
Roquefort and Camembert.
We believe that, though rare, molds should be considered 
a potential cause of food allergy in patients who have ingested 
fermented sausage or cheese. This is particularly relevant in 
asthmatic patients sensitized to molds by inhalation. It is also 
important to always try to determine the cause of a patient’s 
allergy in order to prevent potentially severe reactions in the 
future.
We have reported one of the few cases of food allergy to 
Penicillium and Mucor spp. in the skin of dry Spanish sausage. 
We demonstrated that IgE-mediated hypersensitivity to the 
isolated molds was responsible for the patient’s reaction and 
consider that primary sensitization probably occurred by the 
respiratory route as our patient was an asthmatic previously 
sensitized to molds.
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Nonimmediate allergic reactions to ß-lactams can 
appear within an hour of drug intake but onset is usually 
after 24 to 48 hours. Typical symptoms are maculopapular 
exanthema and late-onset urticaria. The most common 
ß-lactams involved in nonimmediate allergic reactions are 
aminopenicillins [1,2], although cephalosporins are gaining 
importance [3]. A T cell–mediated effector response has been 
shown to be involved [4], although the exact mechanisms 
are not completely understood [5,6]. We report the case of a 
patient with acquired C1 inhibitor defi ciency who developed 
drug rash with eosinophilia and systemic symptoms (DRESS) 
after penicillin V administration.
The patient, a 44-year-old man, had developed acute facial 
and laryngeal angioedema requiring tracheotomy. We detected 
low antigenic (2 mg/dL) and functional C1 inhibitor levels 
(40% of normal values) as well as a decrease in C4 (1 mg/dL) 
and C1q (70 mg/L) levels. An abdominal ultrasound showed 
giant splenomegaly (>30 cm). The patient was diagnosed 
with acquired C1 inhibitor deficiency secondary to non-
Hodgkin lymphoma. The spleen was excised and penicillin 
V treatment was initiated at 800 mg/day for pneumococcal 
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Figure. Percentage of T cells expressing different markers at different time points. A, CD3, CD4, CD8 and CD16 
expression. B, HLA-DR expression in CD4 and CD8 subpopulations. C, granzyme B expression in CD4, CD8 and 
natural killer (NK) subpopulations. D, perforin expression in CD4, CD8, and NK subpopulations.
prophylaxis. Five days after the start of treatment, the patient 
developed a maculopapular exanthema on the trunk and arms 
with fever (39ºC). Treatment was continued for 2 days but 
the lesions spread and the patient continued with persistent 
fever and considerable malaise. Penicillin V was replaced 
by levofl oxacin and sulfonamides, and the fever and malaise 
subsided 3 days later. The maculopapular exanthema persisted 
for 1 week, however, but then began to disappear progressively 
until it had fully cleared by day 15. Serology was negative for 
Toxoplasma gondii, Treponema pallidum, Rubeola, parvovirus 
B19, cytomegalovirus, Epstein-Barr virus, human herpes 
virus 6, and hepatitis B and C virus.
A skin biopsy was processed for hematoxylin-eosin 
and immunohistochemical staining [3] using the following 
polyclonal antibodies: CD4 (Novocastra Laboratory, Newcastle 
upon Tyne, UK), CD8, CD45RO, and HLA-DR (Dako, Ely, 
Cambridgeshire, UK) and CLA (BD Pharmingen, San Diego, 
California, USA). There was a high T-cell infi ltrate, with a 
predominant expression of CD8+ cells compared to CD4, CLA 
and HLA-DR cells at the perivascular site and the dermal-
epidermal junction. All of these markers were also found, but to 
a lesser extent, in the epidermis, where moderate keratinocyte 
death was observed with hematoxylin-eosin. 
The patient was observed from day 2 after onset of the 
reaction until day 30, with determination of eosinophils, 
liver enzymes (aspartate aminotransferase [AST] and alanine 
aminotransferase [ALT]), T-cell subpopulations (CD4+, CD8+, 
and natural killer [NK] cells), and activation (HLA-DR) and 
cytotoxic markers (perforin and granzyme) in peripheral 
blood mononuclear cells [4] with the following monoclonal 
antibodies: CD3-PerCP, CD4-APC, CD8-APC, HLA-DR-PE, 
CD16-FITC, perforin-FITC and granzyme B-PE (Becton-
Dickinson, San Jose, California, USA). There was a parallel 
increase in eosinophil cell counts and liver enzymes that peaked 
on day 7 with 1457.92 eosinophils/mL, 795 IU/L ALT, and 
210 IU/L AST. An increase was also seen in the percentage of 
activated CD8+ T cells (HLA-DR) and cytotoxic marker levels 
(granzyme and perforin). The increase in NK cells was lower 
and there was a marked decrease in CD4+ T cells (Figure). 
One month after the reaction subsided, patch testing [6] 
using major and minor determinants of benzylpenicillin 
(Diater, Madrid, Spain), amoxicillin (GSK, Madrid, Spain) 
and penicillin V (ERN, Barcelona, Spain) was negative at 48, 
72, 96 hours. Lymphocyte transformation tests (LTT) with 
penicillin V, amoxicillin, and benzylpenicillin at different 
concentrations (100, 50 and 10 µg/mL) were positive in all 
cases (stimulation index [SI], >2), with a maximum SI of 3.5 
at the highest penicillin V concentration. 
We have presented the case of a patient who developed 
a nonimmediate reaction to penicillin V, confi rmed by LTT. 
Monitoring acute response indicated a preferential participation 
of CD8+ T cells and cytotoxic mechanisms. To the best of 
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our knowledge, this is the fi rst report of DRESS induced by 
penicillin V with detailed monitoring of allergic response. 
This is of note because such reactions are usually caused by 
aminopenicillins. It is not known whether or not the patient’s 
immunological status might have contributed to the induction 
of the reaction. 
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Hereditary angioedema (HAE) is a rare genetic disease 
with an autosomal dominant inheritance pattern caused by 
C1 inhibitor (C1INH) defi ciency [1]. Urticaria is not typically 
associated with HAE but it can occur in some patients, although 
in mild forms and for short periods of time [2]. 
A 22-year-old female Brazilian student diagnosed with 
HAE 13 years earlier was admitted to the Rio de Janeiro 
Federal University Hospital in January 2006. Her history 
revealed angioedema attacks once or twice a year. These 
episodes became more frequent (once weekly) when she 
started to use oral contraceptives. The episodes disappeared 
when she stopped using the contraceptives and started to take 
ε-aminocaproic acid (3 g daily). 
Five months later, during a routine visit, the patient 
complained of foot pruritus and pain that appeared after 
a couple of hours of walking, as well as edema and pain 
caused by pressure on the skin (when carrying a heavy bag, 
for example). These symptoms improved after 4 to 6 hours. 
She also reported wheal and fl are around lesions that had 
started 8 weeks earlier, mostly affecting her legs and feet and 
worsening after scratching. These reactions generally lasted 
about 1 to 4 hours.
Her family history was remarkable for HAE in her mother 
and in 2 cousins, who had both developed fatal laryngeal 
edema. 
Laboratory tests included serum tests, physical urticaria 
challenge tests, and an autologous serum skin test (ASST). 
Serum test results were within normal limits except for C1INH 
(5 mg/dL) and C4 (4 mg/dL), confi rming the diagnosis of HAE. 
The ASST, delayed pressure urticaria, and dermatographism 
challenge tests were positive (Figure).
The patient was advised to avoid situations that could 
cause delayed pressure urticaria. She was also prescribed 
hydroxyzine at 25 mg/d to control autoimmune chronic 
urticaria (AICU) and dermatographism.
The estimated prevalence of HAE is 1 case per 150 000 
population [1]. Age of onset is variable, and the condition 
may present before the age of 1 year [3]. HAE is characterized 
by recurrent nonwhealing and nonpruritic swelling, which 
typically affects the face, the extremities, and the genitals and 
lasts for 2 to 5 days. Recurrent abdominal pain is reported 
in 70% to 80% of patients. It is a life-threatening disease 
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Figure. Dermatographism lesions on the patient’s back.
because if the swelling affects the larynx, it can cause death by 
asphyxia [2]. Symptoms often worsen with estrogen-containing 
birth control pills or hormone replacement therapy [4]. 
Our patient had long-lasting physical urticaria and a 
positive ASST and was diagnosed with delayed pressure 
urticaria after being submitted to the Warin test [5]. However, 
it is important to point out that microtrauma can cause edema 
in patients with HAE. In such cases, however, lesions appear 
immediately after the trauma, and pain and redness of the skin 
are usually mild or even absent. In delayed pressure urticaria, 
lesions appear between 30 minutes and 9 hours after trauma 
and they are usually painful and/or characterized by a local 
burning sensation and erythema.
Kinins probably play a role in delayed pressure urticaria. 
One possible explanation would be that the pressure reduces 
tissue oxygenation, generating local acidosis, which would 
decrease kininase function, and in turn increase kinin levels, 
causing local edema [6].
The present case shows a rarely described association. It 
is well known that patients with HAE do not typically have 
concomitant urticaria. Our patient had been diagnosed with 
HAE in childhood and in her early twenties had started to 
complain of urticaria attacks, mainly after pressure was applied 
to her skin. 
We believe that the concomitance of HAE and delayed 
pressure urticaria in this patient might be explained by the 
participation of kinin peptides in both conditions. 
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Nonsteroidal antiinflammatory drugs (NSAIDs) have 
antiinfl ammatory, analgesic, and antipyretic effects and are 
among the drugs that most commonly cause adverse reactions. 
The main mechanism underlying the antiinfl ammatory action 
of these drugs is inhibition of the enzyme cyclooxygenase 
(COX), which has 2 known isoforms: the constitutive COX-1 
isoform and the inducible COX-2 isoform, each with different 
characteristics.
Practitioner’s Corner
 J Investig Allergol Clin Immunol 2009; Vol. 19(4): 321-339© 2009 Esmon Publicidad
329
Table. Clinical Characteristics of Patients and Results of Challenge Tests
 Patient 1 2 3 4 5 6 7 8
Sex  Woman Woman Woman Woman Woman Woman Woman Woman  
Age, y  50 55 64 38 70 26 42 49
History of
atopy  No Asthma due No Rhinitis and No No No No
   to dust mites  asthma due
     to dust mites
Drugs involved Ibuprofen Acetylsalicylic Ibuprofen Ibuprofen Aceclofenac Ibuprofen Naproxen Ibuprofen
in NSAID  acid,  diclofenac, diclofenac, diclofenac,   Paracetamol
intolerance  paracetamol, aceclofenac, paracetamol ibuprofen,   1 g
reaction  diclofenac piroxicam 1 g indomethacin,   
      piroxicam, 
      paracetamol,
      etoricoxib
Symptoms Dyspnea Palm itch Undefi ned Generalized Eyelid and Itchy rash Generalized Eyelid
  (uvula and  cutaneous cutaneous facial edema on the trunk cutaneous angioedema
  edema) generalized rash rash and   rash 
   urticaria  dyspnea   
Paracetamol Not tested; Not tested: Tolerance to Positive Positive Positive Tolerance to Tolerance to
  tolerance to (involved in 500 mg, reaction to   1 g 500 mg
  650 mg at intolerance positive doses of  
  home reaction) reaction to 1 g less than  
     500 mg
Meloxicam Positive Positive Positive Positive Positive Positive Positive Positive
Etoricoxib Not tested Tolerated Not tested Tolerated Positive Positive Positive Not tested
   (90 mg)  (60 mg)
Celecoxib Positive Positive Positive Positive Positive Positive Tolerated Tolerated
Other drug ß-lactams ß-lactams, ß-lactams ß-lactams No ß-lactams No No
allergies  lidocaine        
Intolerance reactions to NSAIDs are common and caused 
by inhibition of the COX-1 enzyme. Selective COX-2 NSAIDs 
have been associated with a lower frequency of side effects than 
nonselective NSAIDs and may therefore be a safe alternative 
for use in patients with NSAID intolerance. 
Selective COX-2 inhibitors are currently classifi ed as 
preferential or specifi c. The fi rst group includes “preferably” 
selective COX-2 inhibitors such as nimesulide (withdrawn 
from the market) and meloxicam, which are both signifi cantly 
better inhibitors of COX-2 than of COX-1. This selectivity for 
COX-2, however, decreases with increasing doses. The second 
group encompasses drugs such as celecoxib, etoricoxib and 
rofecoxib (withdrawn) that are much more selective in terms 
of inhibiting COX, even with increasing doses.
We retrospectively evaluated data from 8 patients found to 
have COX-2 inhibitor intolerance on referral to our department 
for evaluation of NSAID intolerance. 
In patients in whom more than 1 family of NSAIDs was 
involved in the reactions, paracetamol and COX-2 inhibitors 
were tested, and in patients in whom only 1 NSAID was 
involved and tolerance to other NSAID families had not been 
previously tested, the implicated NSAID was tested fi rst except 
when the patient preferred to start with an alternative.
Single-blind placebo-controlled oral challenge tests were 
performed with paracetamol (cumulative dose, 1 g), meloxicam 
(cumulative dose, 22.5 mg), celecoxib (cumulative dose, 
400 mg) and/or etoricoxib (cumulative dose, 90 mg). The 
clinical characteristics of each patient and the results of the 
challenge tests performed are shown in the Table.
Meloxicam and celecoxib were tested in all patients and 
etoricoxib was tested in all patients but 3. All of the patients 
reacted to meloxicam (angioedema or cutaneous rash), 2 
patients tolerated etoricoxib but not celecoxib, and 1 patient 
tolerated celecoxib and not etoricoxib. Four patients tolerated 
paracetamol but only 1 of these tolerated the 1-g dose. Finally, 
the only 2 patients that tolerated celecoxib also tolerated 
paracetamol.
Although our series was small, it is striking that all of the 
patients were women, that a large percentage were also allergic 
to other drugs, and that they all had mucosal or cutaneous 
involvement.
Numerous safety and tolerance studies have been conducted 
in patients with NSAID intolerance since COX-2 inhibitors 
became available [1-3] and selective COX-2 inhibition has 
been implicated in the symptoms of bronchial asthma induced 
by acetylsalicylic acid [4].
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Apart from the role that these drugs may play in NSAID 
intolerance, a variety of adverse reactions have been 
described for COX-2 inhibitors [5-9].The existence of genetic 
polymorphisms postulated by some authors [10] might explain 
the differences detected in terms of tolerance to etoricoxib 
and celecoxib, but these differences might also be related to 
the different inhibitory potency of these drugs (half maximal 
inhibitory concentration [IC50] COX-2:IC50 COX-1 ratio of 
30 for celecoxib and 344 for etoricoxib).
The variability of reported results has led to the 
recommendation that COX-2 inhibitors should be tested by 
an experienced allergist before being used in patients with 
analgesic intolerance [4-9]. More studies are needed to assess 
possible risk factors for intolerance to COX-2 inhibitors, as 
well as possible cross-reactions.
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A 26-year-old woman was hospitalized for a dental operation. 
Before discharge, she received intravenous methylprednisolone 
succinate (MP-SS), omeprazole, and parecoxib consecutively. She 
experienced generalized itching, facial angioedema, bronchospasm, 
and shock within 5 minutes of administration. The patient recovered 
after receiving adrenaline and intravenous fl uids.
She had no other chronic diseases or previous exposure 
to systemic corticosteroids. In the past, she had occasionally 
used ocular and cutaneous corticosteroids (dexamethazone) 
because of infectious conjunctivitis and fi nger warts. Using 
NaCl 0.9%, we prepared dilutions of MP-SS (initial solution, 
62.5 mg/mL) and hydrocortisone succinate (HC-SS) (initial 
solution, 125 mg/mL) ranging from 1:1 to 1:10 000. 
We performed a skin prick test (SPT) with 3 different 
dilutions (1:1, 1:10, and 1:100) and an intradermal test 
(IDT) with both MP-SS and HC-SS at a dilution of 1:10 000 
(Table), and the results for both were positive. The results 
were negative for 5 healthy control patients. The results of 
specifi c immunoglobulin (IgE) determination in serum (CAP-
fl uoroenzyme immunoassay, Phadia Laboratories, Uppsala, 
Sweden) were negative for MP-SS.
We also performed SPT and IDT with injectable 
omeprazole and injectable parecoxib, and the results were 
negative. The results of SPT at a dilution of 1:1 dilutions and 
IDT at 1:10 to 1:1000 dilutions using injectable prednisolone 
(25 mg/mL), dexamethazone phosphate  (4 mg/mL), 
betamethasone acetate (3 mg/mL), methylprednisolone acetate 
(20 mg/mL), chloramphenicol succinate (100 mg/mL), and MP-
SS preservative were all negative. SPT with a hydrocortisone 
tablet (20 mg) and methylprednisolone tablet (16 mg) were 
also negative. All SPT with aeroallergens, food allergens, and 
latex were negative. The serum tryptase level was normal 
(4.20 µg/L).
The results of oral challenge with methylprednisolone 
tablets (16 mg/tab), prednisolone (20 mg/tab), dexamethazone 
(1 mg/tab), and omeprazole (20 mg/caps), and intravenous 
challenge with parecoxib (40 mg/vial) were negative. All 
challenges were single-blind placebo-controlled and were 
graded using incremental doses (1:100, 1:30, 1:10, 1:3, and 1:1) 
of 1 tablet or 1 vial of drug every 30 minutes. Challenges with 
MP-SS and HC-SS were not performed for ethical reasons.
Although corticosteroids are widely used, anaphylactic 
reactions to these agents are infrequent. However, they can be 
Practitioner’s Corner
 J Investig Allergol Clin Immunol 2009; Vol. 19(4): 321-339© 2009 Esmon Publicidad
331
Table 1. Patient Characteristicsa
 Drug SPT IDT Challenge
 
Methylprednisolone succinate + 62.5 mg/mL (1:1) 105 mm + 0.00625 mg/mL (1:10.000)
   1013 mm 
ND + 62.5 mg/mL (1:10) 64 mm
 + 0.625 mg/mL (1:100) 5.53mm
Hydrocortisone succinate + 125 mg/mL (1:1) 65 mm + 0.0125 mg/mL (1:10.000) 
  98.5 mm
 + 12.5 mg/mL (1:10) 54 mm
 + 1.25 mg/mL (1:100) 44 mm  
ND
Chloramphenicol succinate – – ND
Methylprednisolone acetate – – ND
Methylprednisolone – – Negative
Hydrocortisone – – ND
Dexamethazone phosphate – – Negative
Betamethasone acetate – – ND
Prednisolone – – Negative
Methylprednisolone succinate
preservatives – – ND
a Positive results are shown with the dilution used and wheal dimensions.
Abbreviations: IDT, intradermal test; ND, not determined; SPT, skin prick test.
life-threatening or fatal [1-3]. The most commonly involved 
agents seem to be MP-SS and HC-SS, because of their high 
affi nity to serum proteins [4-6].
In the case we report, injectable MP-SS was responsible 
for anaphylaxis, as revealed by positive skin test results 
with MP-SS and negative challenge results with omeprazole 
and parecoxib. In addition, IgE antibodies showed high 
epitope specifi city against the succinate moiety of injectable 
methylprednisolone, because skin testing revealed cross-
reactivity only with HC-SS and not with other pure or acetate 
corticosteroid preparations (eg, methylprednisolone acetate). 
Moreover, our patient tolerated an oral challenge with a 
methylprednisolone tablet. Therefore, the succinate part was 
necessary for this reaction to occur and the pure corticosteroid 
molecule was not able to induce the reaction [6]. These 
IgE antibodies did not react with the same succinate salt of 
noncorticosteroid reagents, such as chloramphenicol succinate, 
indicating that a part of the corticosteroid molecule participated 
in the conformation of the responsible epitope. 
Our results confi rm data from previous studies that reported 
positive skin test results with corticosteroid succinate salts 
but not with pure or acetate salts [5-9]. We conclude that the 
reaction in our case was caused by IgE antibodies targeting an 
epitope consisting of the succinate salt and a stereochemical 
part of methylprednisolone. A similar epitope on HC-SS might 
explain the positive skin test result to HC-SS.
Contrary to data in the medical literature, our patient 
had no predisposing risk factors such as hypersensitivity to 
nonsteroidal anti-infl ammatory drugs or previous signifi cant 
exposure to parenteral corticosteroids [2,3,5-10]. Clinicians 
should be aware that severe anaphylactic reactions to 
corticosteroids can occur in any individual, even in the absence 
of predisposing factors. Skin testing with corticosteroids 
seems to be a safe way to reveal sensitization to injectable 
corticosteroids and to find an alternative corticosteroid 
preparation, as verifi ed by challenge tests.
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Figure. Two-dimensional electrophoresis map of chinchilla epithelium 
extract. We observed 2 spots (1 and 2, both weighing 21 kDa).
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Animal allergens are a common cause of both acute and chronic 
allergic disease. Pelt, urine, and saliva from some mammals are 
well-known sources of allergens. Chinchilla (Chinchilla lanigera, 
order Rodentia, family Chinchillidae) is used in the fur industry 
and in certain laboratory experiments; therefore, it is considered 
an occupational source of aeroallergens [1]. However, keeping 
this animal as a pet could make it a potential source of allergens 
in the general population.
We present the case of a 43-year-old woman who 
experienced contact urticaria, rhinoconjunctivitis, and 
persistent asthma as a result of exposure to her pet chinchilla. 
She complained of symptoms when in the presence of the 
animal, although the symptoms disappeared during her 
vacation, when she was not exposed. 
The patient underwent a skin prick test with common 
aeroallergens and a battery of animal epithelium extracts (cat, 
dog, rat, mouse, rabbit, guinea pig, hamster, gerbil, horse, and 
cow). The result was negative for all extracts except chinchilla 
pelt, which produced a wheal measuring 66 mm. 
Peak fl ow monitoring values were 380-400 L/min during 
the 15 days of her vacation (no exposure). When an exposure 
challenge was performed at the owner’s home after the 
vacation, these values fell to 280-300 L/min, and when she 
spent 15 minutes in the room where the animal was kept, 
her peak fl ow decreased to 100 L/min. She also experienced 
respiratory symptoms and contact urticaria.
Total immunoglobulin (Ig) E, determined using ImmunoCAP 
(Phadia AB, Uppsala, Sweden), was 79 kUA/L. Specifi c IgE 
was determined using the enzyme allergosorbent test (EAST) 
inhibition procedure (HY-TEC assay, HYCOR, Garden Grove, 
California, USA). The solid phase was obtained by coupling the 
extract solution (1 mg/mL) to a 6-mm diameter cyanogen bromide 
paper–activated carrier and the EAST inhibition procedure 
(HYCOR) was performed in accordance with the manufacturer’s 
instructions (Specifi c IgE was undetectable for hair extracts from 
cow, cat, dog, and squirrel, and for pelt and urine extracts from 
rat, mouse, guinea pig, hamster, gerbil, and rabbit [2]. Specifi c 
IgE to chinchilla urine and chinchilla pelt extracts were 7.3 kUA/L 
(class 3) and 5 kUA/L (class 3), respectively.
We prefractionated the whole chinchilla pelt extract by 
preparative isoelectric focusing and collected the proteins in 
the chamber at pH 4.6-5.4. These proteins were then separated 
by 2-dimensional electrophoresis using a strip at pH 4.7-5.9 
in the fi rst dimension. In the second dimension, the sodium 
dodecyl sulfate gel had a 4-12% polyacrylamide gradient. After 
immunodetection, we observed 2 spots, both weighing 21 kDa, 
(Figure), and we identifi ed the same 2 proteins in both spots: 
14-3-3 protein kinase C inhibitor-1 isoform and α 2-u-globulin 
L type, which is known as the major rat allergen Rat n 1 and 
belongs to the lipocalin superfamily.
Kelso et al [1] recently reported the allergenic character of 
hair and urine from chinchilla. The most widely reported mammal 
and rodent allergens are serum albumin and lipocalins, whose 
molecular masses range from 62 kDa to 69 kDa and 7 kDa to 
23 kDa, respectively [2-4]. One of the possibly immunoreactive 
proteins detected here belongs to the lipocalin family.
In our case, as the skin prick test and EAST inhibition results 
showed, no cross-reactivity was found between chinchilla 
allergens and those from the other animal epithelia and urines 
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tested. Due to their pheromonal character and function, the 
expression of urine lipocalins in mice and rats is sex-dependent, 
and their amount in urine is about 6 times higher in males than 
females [5]. Therefore, urine from male rodents–the patient’s 
chinchilla was male–could be considered a stronger potential 
allergen source than urine from female rodents.
We describe a case of nonoccupational allergy to chinchilla. 
Current knowledge on rodent allergens and the results of the 
present case lead us to believe that the allergen involved was 
chinchilla lipocalin.
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Table. Laboratory Findings
  
           Patient’s Reference
   Values Range
Leukocytes 12 200/mm3 4000-10 000/mm3
Eosinophils 1260/mm3 ≤350/mm3
Blood glucose 190/mg/dL 55-110 mg/dL
Plasma urea 108 mg/dL 10-50 mg/dL
Serum creatinine 2.6 mg/dL 0.6-1.4 mg/dL
Uricemia 13.2 mg/dL ≤7.5 mg/dL
AST 76 IU/L 20-45 IU/L
ALT 63 IU/L 25-40 IU/L
PCO2 50 mm Hg 35-45 mm Hg
Po2 56 mm Hg 80-90 mm Hg
Blood pH 7.36 7.37-7.43
Total serum IgE 265 kUA/L ≤120 kUA/L
ESR 42 mm at 1 hour ≤15 mm at 1 hour 
Abbreviations: ALT, alanine aminotransferase; AST, aspartate 
aminotransferase; Ig, immunoglobulin; ESR, erythrocyte 
sedimentatiuon rate.
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Allopurinol hypersensitivity syndrome (AHS) is 
characterized by rash, impaired renal function, and acute 
hepatic toxicity (major criteria) in association with fever, 
leukocytosis, and eosinophilia (minor criteria) [1]. Patients 
taking diuretics for chronic renal failure present a high risk of 
drug rash with eosinophilia and systemic symptoms (DRESS) 
syndrome after taking allopurinol [1]. Taking allopurinol 
irregularly seems to be a risk factor [1]. 
A 70-year-old man with gout, hypertension, obesity, 
diabetes mellitus, chronic obstructive pulmonary disease, 
and chronic renal failure (stage 1) developed a DRESS 
syndrome after taking oral allopurinol (300 mg). He had 
previously taken allopurinol for 1 month to treat symptomatic 
hyperuricemia. When the drug was reintroduced, it induced a 
widespread erythematous itching rash, asthenia, dyspnea, facial 
angioedema, and fever (38.5°C-39°C) 12 hours after the third 
tablet was taken. The patient was admitted to hospital. His 
clinical history revealed previous hypersensitivity reactions to 
aspirin and pyrazolone. When the adverse reaction occurred, he 
was also taking glibenclamide, digoxin, losartan, furosemide, 
and formoterol/budesonide. All drugs were stopped during 
hospitalization (Table).
The laboratory workup revealed kidney failure, severe 
dyspnea, and mild mixed acidosis. He was treated with oxygen 
therapy, corticosteroids, antihistamines, 5% glucose solution, 
insulin, and inhaled salmeterol.
Blood pressure, blood glucose level, and renal function 
were closely monitored. The results of serology testing 
for viruses and bacteria were negative. The results of a 
dermatology workup enabled us to make a diagnosis of 
DRESS syndrome induced by allopurinol, but the patient 
refused to undergo a skin biopsy. He was discharged and 
prescribed the drugs he was taking before hospitalization 
(except allopurinol) and a hyperuricemia-specifi c diet. The 
patient did not adhere to the diet and developed hyperuricemia 
(11.5 mg/dL) 1 month later. Sulfi npyrazone was avoided due to 
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the patient’s hypersensitivity to nonsteroidal anti-infl ammatory 
drugs. Desensitization was not performed because of the 
previous severe adverse cutaneous reaction. The patient 
refused colchicine because he feared experiencing adverse 
events. Since cutaneous lesions were still present 45 days 
after the acute episode, no skin tests were performed [2]. A 
rapid single-dose oral challenge test with potassium-sodium-
hydrogen citrate (Rottapharm-Madaus, srl, Padova, Italy) was 
performed as described elsewhere [3]. The patient tolerated this 
drug well, and was prescribed a 10-day regimen (200 mg bid) 
to reduce his uricemia (7.2 mg/dL).
Two months later, when the skin lesions had faded 
completely, he underwent a patch test with allopurinol 
10% and 5% in petrolatum [2] according to the guidelines 
of the European Academy of Allergology and Clinical 
Immunology [4]. The results at 48, 72, and 96 hours, and a 
scratch-patch test gave doubtful results after 24 hours. The 
patient again refused to undergo a skin biopsy. 
Positive skin test results to allopurinol are infrequent. 
Emmerson et al [5] studied a group of 9 patients with AHS: 
only 2 showed positive responses to intradermal tests at 0.1 µg/
mL of allopurinol and oxypurinol in glycerol. There are no 
reports of positive patch test results with allopurinol in the 
literature [2]. 
Recently, rasburicase (produced by genetic engineering of 
Aspergillus fl avus uricase) has been proposed as an alternative 
in patients with gout [6]. It could also prove useful in patients 
with gout and AHS, although its disadvantages include 
parenteral administration, risk of anaphylactic reaction, high 
cost, and absence of validated treatment schedules. These 
limitations and the patient’s poor adherence history prevented 
us from prescribing rasburicase to our patient.
In patients with AHS, we recommend a short course of 
potassium-sodium-hydrogen citrate while awaiting approval 
for the new safer molecules (febuxostat) that are now available 
in the USA [7]. 
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Dimenhydrinate is an H
1
 antihistamine of the ethanolamine 
group with important anticholinergic, antiserotoninergic, and 
sedative properties. Ethanolamine compounds have been 
used to treat dizziness, nausea, vomiting, anxiety, and cold 
symptoms. Diphenhydramine, from which dimenhydrinate, 
doxylamine, carbinoxamine, and clemastine derive, also 
belongs to this group. 
We present the case of a 17-year-old woman who 
presented several times during a 1-year period with 2 round 
erythematous macules on the abdomen and right gluteus after 
taking combined dimenhydrinate and acetaminophen for 
dysmenorrhea. The lesions disappeared after 6-7 days, leaving 
a hyperpigmented residual lesion. The patient later tolerated 
acetaminophen.
Patch testing was performed with dimenhydrinate and 
acetominophen and dimenhydrinate 10% in petroleum jelly 
on the affected areas and on areas of healthy skin. Readings 
were taken at 48 and 96 hours. The results were positive 
for dimenhydrinate on the right gluteus (Figure) and for the 
combination on the abdomen at 48 and 96 hours. The results of 
patch testing on 10 controls with dimenhydrinate at the same 
concentration were negative. The results of patch testing with 
antihistamines from other groups–cetirizine, rupatadine, and 
dexchlorpheniramine–were negative.
Given the patient’s history and the patch test results 
to dimenhydrinate, an oral challenge with this drug was 
considered unnecessary.
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Figure. Patch test on previously affected skin (right gluteus): 1. 
Dimenhydrinate, 2. Negative control.
Controlled oral exposure to cetirizine, rupatadine, and 
dexchlorpheniramine was well tolerated. The patient also applied 
treatment at home with each of these medications for 5 days with 
no skin reaction. Fixed drug eruption (FDE) is a rash characterized 
by one or more well-delimited erythematous lesions that appear 
shortly after ingesting the causal agent and typically recur in the 
same location when the agent is reintroduced. A hyperpigmented 
area sometimes remains after the symptoms have subsided. 
Sulphonamides, nonsteroidal anti-infl ammatory drugs, ß-lactam 
antibiotics, barbiturates, and tetracyclines are the most common 
causal agents [1]. With respect to antihistamines, cases of FDE due 
to loratadine [2], cetirizine [3], hydroxyzine [3], levocetirizine [4], 
and diphenhydramine [5] have been reported. There are few 
known cases of dimenhydrinate-induced FDE [6-8], and none in 
which tolerance of other antihistamines was confi rmed by oral 
challenge.
Our patient had a positive reaction when the medication 
was tested on previously affected skin. This supports the 
idea that patch testing should be performed on areas of 
residual lesions in FDE, thus obviating oral challenge tests, 
which are not exempt from risks. Our patient tolerated 
antihistamines from other groups (cetirizine, rupatadine, and 
dexchlorpheniramine), indicating that there was no cross-
reactivity with the antihistamines tested. 
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Fanconi anemia is an autosomal recessive disease 
characterized by cellular hypersensitivity to DNA cross-linking 
agents and progressive bone marrow failure. Patients with this 
condition often present with recurrent infections resulting 
from immunodeficiencies. Immunologic abnormalities 
that have been described in patients with Fanconi anemia 
include reduced natural killer cell activity [1,2], low levels 
of production of interleukin 6 [3], and high plasma levels 
of tumor necrosis factor alfa-α [1,4]. In addition, selective 
immunoglobulin (Ig) A defi ciency has been described in a 
case report [5]. In our review of the literature, we came across 
only 1 study that addressed humoral immunity in patients 
with Fanconi anemia, and there have been no reports of 
accompanying hypogammaglobulinemia. We discuss a patient 
with Fanconi anemia and hypogammaglobulinemia.
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A 35-year-old male with Fanconi anemia and squamous 
cell carcinoma of the larynx complicated by multiple neck 
dissections presented with fever and chest pain. He was 
diagnosed with bacterial pericarditis caused by methicillin-
susceptible Staphylococcus aureus and subsequently developed 
bilateral pneumonia. Upon admission his leukocyte count was 
6.2109/L and his hematocrit 32%. His course was complicated 
by constrictive pericarditis and he underwent emergency 
pericardiectomy. He subsequently developed ventilator-
associated pneumonia and a surgical wound infection at the 
site of his chest incision leading to bacteremia. Given these 
recurrent infections in the absence of neutropenia, Ig levels 
were determined, and he was found to have low titers in 
all Ig groups (Table). He received replacement intravenous 
immunoglobulin and responded well. Two months later he was 
readmitted with cellulitis and neutropenia. Despite appropriate 
antimicrobial therapy and concomitant granulocyte colony-
stimulating factor therapy, his fever did not remit. He was 
treated with intravenous immune serum globulin after his titers 
were again found to be low (Table), and his fever subsequently 
fell. He underwent surgery for recurrent left neck carcinoma 
and had an unremarkable postoperative course.
Recurrent infections in patients with Fanconi anemia have 
been attributed to the presence of pancytopenia, particularly 
neutropenia. Immunologic abnormalities described elsewhere 
point towards a defect in cell-mediated immunity. Humoral 
immunity has been evaluated by determination of Ig levels 
in a small number of cases and was reported to be normal 
[3,6,7].
Our patient was initially diagnosed with Fanconi anemia 
at age 21. He later developed squamous cell carcinoma of 
the neck and underwent several surgical interventions. He 
reported postoperative complications in the past, although his 
hematological data and medical records from that time were 
unavailable to us. He initially presented at our hospital with 
pericarditis, and despite being on appropriate antimicrobial 
therapy, he developed several repeated infections over a short 
period, leading us to investigate further the risk factors for 
infection. 
Our rationale in determining Ig levels was based on a study 
by Roxo et al [3], who recorded serum Ig levels in 12 patients 
with Fanconi anemia and their response to vaccination. The Ig 
levels measured were normal except for subclass IgG4, which 
was undetectable in 2 out of 12 patients. 
It could be argued that our patient’s recurring infections 
during his second hospitalization could in fact be from the 
Table. Immunoglobulin Levels
  
  
Immunoglobulin
 Patient  Reference
   Levels in Range in
   mg/dL mg/dL 
Immunoglobulin IgG 224 650-1750
levels during IgM 18 37-250
hospitalization 1
Immunoglobulin IgG 488 650-1750
levels during IgM 19 37-250
hospitalization 2 IgA 83 60-240  
concomitant presence of neutropenia. However, he was not 
neutropenic during his fi rst admission. The etiology of his 
hypogammaglobulinemia is unclear and its development over 
time could not be determined. However, he had a strong clinical 
response after administration of intravenous Ig. To conclude, 
we describe a case of hypogammaglobulinemia as a possible 
cause of immunodefi ciency in Fanconi anemia. Future studies 
should examine the role of humoral immunity in patients with 
this condition. 
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Food-dependent exercise-induced anaphylaxis (FDEIA) is 
characterized by anaphylactic symptoms after exercise preceded 
by ingestion of a food allergen. It was fi rst described in 1979 
in a patient who experienced exercise-induced anaphylaxis 
after eating shellfi sh [1]. FDEIA has been associated with 
wheat, seafood, peanut, eggs, milk, vegetables, and fruit [2]. 
We present a case of FDEIA induced by peach.
An 11-year-old boy experienced anaphylactic symptoms 
(dyspnea, pruritus, diffuse erythematous rash) after eating 
curry, yogurt, cabbage, onion, carrot, potato, green peas, 
rice, and peach for lunch. He ate the peach approximately 
2 hours before playing football. Two months previously, he 
had experienced similar symptoms closely related to exercise 
2.5 hours after eating peach, but exercise alone had never 
generated a reaction. He had a history of allergic rhinitis, but 
no food allergy. His father also had a history of allergic rhinitis. 
On admission, 3 months after the initial anaphylaxis, physical 
examination revealed no signifi cant fi ndings. He did not have 
eosinophilia, but he did have high serum immunoglobulin (Ig) E 
(1070 U/mL) titers and peach-specifi c IgE was 8.08 kUA/mL. 
Latex-specifi c IgE testing was negative. Open-labeled oral 
challenge tests, which were performed using 50 g (wet weight) 
of peach, failed to induce any allergic reactions. He showed 
no symptoms after ingestion of the peach, and a 20-minute 
treadmill test using the standard Bruce protocol was performed 
60 minutes after food intake. Blood pressure and pulse rate 
were monitored during the challenge test. Ingestion of this 
food, followed by exercise, led to mild pruritus and small 
urticaria on the left arm. Forced expiratory volume in 1 second 
and forced vital capacity were measured before and after 
exercise, and there was no change in his lung function after 
exercise. Therefore, ingestion of peach followed by exercise 
did not induce anaphylaxis. We administered 500 mg of oral 
aspirin followed by peach 30 minutes later and a treadmill test 
6 minutes after peach intake [3]. Aspirin and peach induced 
anaphylactic reactions (dyspnea, pruritus, diffuse erythematous 
rash). We treated the patient with an intramuscular injection 
of epinephrine antihistamine and corticosteroids. Five hours 
after ingestion, he had completely recovered. However, 
aspirin loading did not induce an allergic reaction. The patient 
was advised to avoid peach and has experienced no further 
reactions. We prescribed self-injectable epinephrine. 
Aspirin is a known trigger of anaphylaxis in patients 
who experience FDEIA. Harada et al [3] fi rst confi rmed the 
effects of aspirin on the induction of food anaphylaxis, even 
in patients with FDEIA who had no previous history of aspirin 
hypersensitivity caused by nonsteroidal anti-infl ammatory 
drugs. This observation suggests 2 possible mechanisms 
in the elicitation of symptoms: aspirin could upregulate 
antigen uptake across the intestinal epithelium and into the 
bloodstream, and/or aspirin itself could activate mast cells 
in combination with IgE cross-linking through an unknown 
mechanism [4].
Shellfish is the most common allergen in the United 
States [5]. The most common specifi c food allergen in FDEIA 
is wheat [1], and, in particular, ω-5 gliadin. However, there 
have been few reports of this condition after peach ingestion 
in childhood [6]. The cause of FDEIA is not well understood, 
although cross-reactivity exists between pollen and Rosaceae 
fruit allergens that cause oral allergy syndrome. Thus, further 
studies are needed to establish the clinical signifi cance of the 
observed cross-reactivity between aeroallergens and FDEIA. 
Our results confi rm that peach can induce FDEIA. 
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Figure. Highly magnifi ed photomicrograph showing the esophageal 
epithelium infi ltrated by a large number of polymorphonuclear eosinophils 
(more than 20 per high power fi eld).  Hematoxylin-eosin 400.  
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Eosinophilic esophagitis (EE) is characterized by the 
presence of a biopsy-proven infl ammatory eosinophilic infi ltrate 
in the esophageal mucosa [1]. Its presentation is similar to that 
of gastroesophageal refl ux disease, and it responds poorly to 
antirefl ux treatment. In children, the commonest symptoms 
are abdominal pain and vomiting, whereas adults experience 
dysphagia and food impaction [2]. Over 60% of patients have 
a history of atopy, and sensitization to foods or aeroallergens 
is common, with clinical improvement after switching to an 
elementary or exclusion diet [3]. 
A 32-year-old man presented with a 10-year history of 
mild seasonal rhinoconjunctivitis for which he took only 
antihistamines as needed. He had never received immunotherapy. 
For the last 2 years, he had experienced oral pruritus after eating 
fresh, raw fruit and vegetables. However, as the pruritis was 
mild, he did not stop eating these foods. He tolerated cooked 
vegetables, jams, and pasteurized fruit juices. Furthermore, in 
the last year, he suffered dysphagia with solids. Omeprazole 
made no improvement to his symptoms, and gastroesophageal 
refl ux disease was ruled out by pH monitoring. 
Skin prick tests were performed with commercial 
standardized extracts of pollen, mites, danders, moulds, latex, 
Anisakis simplex, profi lin, and standardized Pru p 3 peach 
extract (ALK-Abelló, Madrid, Spain), shellfi sh, molluscs, 
cephalopods, fruit, vegetables, fi sh, cereal fl ours, nuts, milk, 
egg, lentils, soya, and spices (Leti, Barcelona, Spain). The 
patient presented positive results for the following allergens 
(wheal size): grass pollen (10 mm), olive (4 mm), cat dander 
(4 mm), tomato (5 mm), melon (7 mm), orange (3 mm), and 
profi lin (12 mm). Total immunoglobulin (Ig) E was 78 kUA/L. 
Specifi c IgE was <0.35 kUA/L in Ole e 1 and elevated for 
tomato (2.53 kUA/L), grass pollen (6.44 kUA/L) and profi lin in 
Phleum pratense (5.96 kUA/L) (CAP System, Phadia, Uppsala, 
Sweden), Mal d 4 (2.96 kUA/L), Pho d 2 (9.59 kUA/L), and 
Cuc m 2 (2.20 kUA/L) (ADVIA-Centaur, Bayer HealthCare 
Diagnostics Division, Tarrytown, New York, USA). A complete 
blood count (January 2008) showed 490 eosinophils/µL, although 
the serum determination for eosinophil cationic protein (ECP) 
(CAP System) was clearly elevated (88.6 µg/L). The results for 
the remaining biochemistry parameters and the complement 
and immunoglobulin studies were normal. Gastroendoscopy 
showed a morphologically normal esophageal mucosa with a 
nonstenotic mucous ring in the transition zone. Biopsy revealed 
a clear predominantly eosinophilic infi ltrate (Figure).
Fruit and vegetables were only permitted if cooked. Four 
months later, the patient was asymptomatic and ECP serum 
levels had fallen to 40.1 µg/L. 
Although its origin is unknown, EE is an increasingly common 
entity in which food and aeroallergens appear to play a role [4]. 
This patient had already presented mild allergic rhinitis. This 
prior sensitization to grass pollen may explain the subsequent 
sensitization to profi lins, as structural plant proteins show a large 
degree of homology and cross-reactivity, thus enabling them to 
act as panallergens [5]. Profi lins cannot resist the action of gastric 
proteases, but are barely affected by saliva, which is why the 
patient only presented oral and esophageal symptoms, and no 
gastric or systemic involvement. Furthermore, profi lins are heat-
labile, hence the good response to cooked vegetables. Remission 
of the infl ammatory infi ltrate should have been confi rmed by 
endoscopy; however, the patient rejected this option because he 
was feeling clinically well. The notable decrease in serum ECP [6], 
together with the disappearance of clinical symptoms, indicates 
that by simply strictly avoiding the allergen, as is the case in other 
allergic diseases, the clinical symptoms will disappear. Inhaled 
fl uticasone could have accelerated the improvement, but it was 
considered unnecessary once the positive results of a change in 
diet had been observed. 
In conclusion, this case of EE was probably associated 
with sensitization to profi lin, although strict exclusion of 
foods containing the protein led to remission of symptoms. 
We believe that a meticulous allergy workup is fundamental 
to identify potential allergens in this condition. 
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The following are corrections for typographical errors that occurred in the article above.
Table 1
Diagnostic Test 2005 1992
Skin prick test  100 100
Diagnostic Test 2005 1992
Skin prick test  96 98
Treatment
– Immunotherapy was prescribed in 38% of patients with RA
should read
– Immunotherapy was prescribed in 31% of patients with RA
Discussion
– Specifi c immunotherapy, ... was indicated in 38% of patients with AR. This fi gure is much lower than that from 
Alergológica-92 where it was prescribed in 58%...
should read
– Specifi c immunotherapy,... was indicated in 31% of patients with AR. This fi gure is much lower than that from 
Alergológica-92 where it was prescribed in 45%...
Table 2.
Treatment   2005 1992
Nasal steroids   68 58
Specifi c immunotherapy 31 58
should read
Treatment   2005 1992
Nasalsteroids   67 58
Specifi c immunotherapy 31 45
